MedTrace Logo

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

NCT06981156 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2026-07-21

No results posted yet for this study

Summary

This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.

Conditions

  • Pediatric Brain Tumor
  • Pediatric Spine Tumor

Interventions

DIAGNOSTIC_TEST

pNANO Assessment

pNANO assesses patient gait, strength, cerebellar function, visual fields, visual acuity, facial strength, level of consciousness, extraocular movement, dysarthria, and dysphagia The patient will be assessed by 2-3 different clinicians during each of 2 visits.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Austin Stuckert, MD · UW School of Medicine and Public Health

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-13
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06981156 on ClinicalTrials.gov